Related references
Note: Only part of the references are listed.The Risks of miRNA Therapeutics: In a Drug Target Perspective
Song Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Xiaolin Wang et al.
GUT (2021)
Lipid nanocarriers for microRNA delivery
Marcel Scheideler et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2020)
The entry of nanoparticles into solid tumours
Shrey Sindhwani et al.
NATURE MATERIALS (2020)
2019 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2020)
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target
Lorena Baboci et al.
JOURNAL OF ONCOLOGY (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
Nanomedicine and the COVID-19 vaccines
[Anonymous]
NATURE NANOTECHNOLOGY (2020)
Tumor-triggered personalized microRNA cocktail therapy for hepatocellular carcinoma
Shiyi Shao et al.
BIOMATERIALS SCIENCE (2020)
MicroRNA miR-100 Decreases Glioblastoma Growth by Targeting SMARCA5 and ErbB3 in Tumor-Initiating Cells
Bahauddeen M. Alrfaei et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma
Grace T. Y. Kwok et al.
ONCOLOGIST (2019)
The role and mechanisms of action of microRNAs in cancer drug resistance
Wengong Si et al.
CLINICAL EPIGENETICS (2019)
MicroRNAs and Long Non-Coding RNAs and Their Hormone-Like Activities in Cancer
Barbara Pardini et al.
CANCERS (2019)
Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma
Young-Eun Seo et al.
BIOMATERIALS (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The Potential for microRNA Therapeutics and Clinical Research
Johora Hanna et al.
FRONTIERS IN GENETICS (2019)
Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy
Alessandro Bertucci et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Programmed death-ligand 1 monoclonal antibody-linked immunoliposomes for synergistic efficacy of miR-130a and oxaliplatin in gastric cancers
Fengyong Wang et al.
NANOMEDICINE (2019)
Delivery of biologically active miR-34a in normal and cancer mammary epithelial cells by synthetic nanoparticles
Fabiana Panebianco et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Exosome-mimetic nanoplatforms for targeted cancer drug delivery
Abi J. Vazquez-Rios et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Anti-GPC3 Antibody Tagged Cationic Switchable Lipid-Based Nanoparticles for the Co-Delivery of Anti-miRNA27a And Sorafenib in Liver Cancers
Zhengfeng Wang et al.
PHARMACEUTICAL RESEARCH (2019)
Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide
Uday K. Sukumar et al.
BIOMATERIALS (2019)
2018 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2019)
Enhanced Chemotherapeutic Efficacy of Paclitaxel Nanoparticles Co-delivered with MicroRNA-7 by Inhibiting Paclitaxel-Induced EGFR/ERK pathway Activation for Ovarian Cancer Therapy
Xiaojuan Cui et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity
Florian Schueller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
Feng Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Inorganic nanoparticles: A potential cancer therapy for human welfare
Arivalagan Pugazhendhi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention
Nicholas H. Farina et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN
Julia Ramirez-Moya et al.
ONCOGENE (2018)
The role of microRNAs and nanoparticles in ovarian cancer: a review
Leila Kafshdooz et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection
Vrantika Chaudhary et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Editorial: MicroRNAs as New Players in Endocrinology
Chun Peng et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
Prashanth K. B. Nagesh et al.
CANCERS (2018)
MicroRNA-34 family in breast cancer: from research to therapeutic potential
Saber Imani et al.
JOURNAL OF CANCER (2018)
Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells
Berrin Kucukturkmen et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2018)
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
Muhammad S. Beg et al.
INVESTIGATIONAL NEW DRUGS (2017)
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk et al.
LANCET ONCOLOGY (2017)
MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours
Anna L. Leichter et al.
MOLECULAR CANCER (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells
Meike Kaehler et al.
ONCOTARGET (2017)
microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma
Hirofumi Yoshino et al.
ONCOTARGET (2017)
Therapeutic effects of long-circulating miR-135a-containing cationic immunoliposomes against gallbladder carcinoma
Guanghua Yang et al.
SCIENTIFIC REPORTS (2017)
MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis
Y-L Li et al.
ONCOGENESIS (2017)
Dynamic and Modularized MicroRNA Regulation and Its Implication in Human Cancers
Jiang Shu et al.
SCIENTIFIC REPORTS (2017)
Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research
Guillermo Aquino-Jarquin
CANCER RESEARCH (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticles
Desiree Van Haute et al.
THERAPEUTIC DELIVERY (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Engineering exosomes as refined biological nanoplatforms for drug delivery
Xin Luan et al.
ACTA PHARMACOLOGICA SINICA (2017)
Polymeric micelles as mighty nanocarriers for cancer gene therapy: a review
Mahsa Yousefpour Marzbali et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Jennifer I. Hare et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma
M. H. van der Ree et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
MicroRNA in diagnostics and therapy of thyroid cancer
Anna Wojcicka et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
Xinwei Cheng et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma (vol 29, pg 723, 2016)
Siyuan Zheng et al.
CANCER CELL (2016)
Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma
Sara Jung et al.
ENDOCRINE-RELATED CANCER (2016)
Targeted Delivery of MicroRNA125a-5p by Engineered Lipid Nanoparticles for the Treatment of HER2 Positive Metastatic Breast Cancer
Stephen L. Hayward et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
New polymer of lactic-co-glycolic acid-modified polyethylenimine for nucleic acid delivery
Jian-Ming Lu et al.
NANOMEDICINE (2016)
Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex
Paula Ofek et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
Rajesha Rupaimoole et al.
CANCER DISCOVERY (2016)
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
Shailendra Kumar Dhar Dwivedi et al.
ONCOTARGET (2016)
A Tumor-specific MicroRNA Recognition System Facilitates the Accurate Targeting to Tumor Cells by Magnetic Nanoparticles
Yingting Yu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges
Nadia Cherradi
FRONTIERS IN ENDOCRINOLOGY (2016)
Therapeutics in Cancer - An Emerging Concept
Maitri Y. Shah et al.
EBIOMEDICINE (2016)
Dysregulation of microRNA biogenesis machinery in cancer
Akiko Hata et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
Targeting strategies on miRNA-21 and PDCD4 for glioblastoma
Gang Wang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2015)
Regulatory aspects on nanomedicines
Vanessa Sainz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
miR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma
Lianyong Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA
Tingting Zhang et al.
CANCER LETTERS (2015)
The miR-146b-3p/PAX8/NIS Regulatory Circuit Modulates the Differentiation Phenotype and Function of Thyroid Cells during Carcinogenesis
Garcilaso Riesco-Eizaguirre et al.
CANCER RESEARCH (2015)
MicroRNAs in cancer therapeutics: from the bench to the bedside
Paloma del C. Monroig-Bosque et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
MicroRNA Therapeutics: the Next Magic Bullet?
Bridget Simonson et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy
Sanchaika Gaur et al.
ONCOTARGET (2015)
microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma
Anthony R. Glover et al.
ONCOTARGET (2015)
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
Donato Cosco et al.
SCIENTIFIC REPORTS (2015)
MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy
Peter Igaz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Nanocell targeting using engineered bispecific antibodies
Karin Taylor et al.
MABS (2015)
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
A. L. Kasinski et al.
ONCOGENE (2015)
miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis
Tsung-Hua Hsieh et al.
ONCOTARGET (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer
Anupama Mittal et al.
BIOMATERIALS (2014)
Hyaluronic acid-chitosan nanoparticles for co-delivery of M1R-34a and doxorubicin in therapy against triple negative breast cancer
Xiongwei Deng et al.
BIOMATERIALS (2014)
MicroRNAome Genome: A Treasure for Cancer Diagnosis and Therapy
Ioana Berindan-Neagoe et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4
Fang-ling Ning et al.
DIAGNOSTIC PATHOLOGY (2014)
Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression
Sanjun Shi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells
Asli Ekin et al.
JOURNAL OF GENE MEDICINE (2014)
Gold Nanoparticles for Nucleic Acid Delivery
Ya Ding et al.
MOLECULAR THERAPY (2014)
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Maria Angelica Cortez et al.
MOLECULAR THERAPY (2014)
Integrated genomic characterization of adrenocortical carcinoma
Guillaume Assie et al.
NATURE GENETICS (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues
Zhiyun Guo et al.
SCIENTIFIC REPORTS (2014)
Functional Nanostructures for Effective Delivery of Small Interfering RNA Therapeutics
Cheol Am Hong et al.
THERANOSTICS (2014)
Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets
Christine Spitzweg et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Friend or foe: the role of microRNA in chemotherapy resistance
Haoran Li et al.
ACTA PHARMACOLOGICA SINICA (2013)
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
G. Reid et al.
ANNALS OF ONCOLOGY (2013)
A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells
Rajib Ghosh et al.
BIOMATERIALS (2013)
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients
O. Chabre et al.
ENDOCRINE-RELATED CANCER (2013)
MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells
Tao Yang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
Upregulated miR-155 in Papillary Thyroid Carcinoma Promotes Tumor Growth by Targeting APC and Activating Wnt/beta-Catenin Signaling
Xiaoping Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Progress in microRNA delivery
Yu Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
Shu-hao Hsu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Hui Ling et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Treatment of HCV Infection by Targeting MicroRNA
Harry L. A. Janssen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN
Lin Lei et al.
ONCOLOGY REPORTS (2013)
Functionalized Graphene Oxide Mediated Adriamycin Delivery and miR-21 Gene Silencing to Overcome Tumor Multidrug Resistance In Vitro
Feng Zhi et al.
PLOS ONE (2013)
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
Yun Wu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
Lili Bao et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Reprogramming Tumor-Associated Dendritic Cells In Vivo Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer
Juan R. Cubillos-Ruiz et al.
CANCER RESEARCH (2012)
N-hexanoyl, N-octanoyl and N-decanoyl chitosans: Binding affinity, cell uptake, and transfection
Buddhadev Layek et al.
CARBOHYDRATE POLYMERS (2012)
Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia
S. Kasar et al.
GENES AND IMMUNITY (2012)
MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy
Zhenyou Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Discovering the first microRNA-targeted drug
Morten Lindow et al.
JOURNAL OF CELL BIOLOGY (2012)
Dysregulation of microRNAs in adrenocortical tumors
Puneet Singh et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Synthetic MicroRNA Cassette Dosing: Pharmacokinetics, Tissue Distribution and Bioactivity
Hongyan Wang et al.
MOLECULAR PHARMACEUTICS (2012)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hypoxia-Induced Down-Regulation of microRNA-34a Promotes EMT by Targeting the Notch Signaling Pathway in Tubular Epithelial Cells
Rui Du et al.
PLOS ONE (2012)
Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
Amanda Tivnan et al.
PLOS ONE (2012)
Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7
Felicity C. Kalinowski et al.
PLOS ONE (2012)
MicroRNA Profiling of Adrenocortical Tumors Reveals miR-483 as a Marker of Malignancy
Erin E. Patterson et al.
CANCER (2011)
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
Ahmed Fawzy Ibrahim et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Susanna Leskelae et al.
ENDOCRINE-RELATED CANCER (2011)
The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
Deniz M. Ozata et al.
ENDOCRINE-RELATED CANCER (2011)
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Bogdan Mateescu et al.
NATURE MEDICINE (2011)
The ClinicalTrials.gov Results Database - Update and Key Issues
Deborah A. Zarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Upregulation of miR-21 by Ras in vivo and its role in tumor growth
D. Frezzetti et al.
ONCOGENE (2011)
MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity
Lei Shi et al.
BRAIN RESEARCH (2010)
The Promise of MicroRNA Replacement Therapy
Andreas G. Bader et al.
CANCER RESEARCH (2010)
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Jason F. Wiggins et al.
CANCER RESEARCH (2010)
Therapeutics Based on microRNA: A New Approach for Liver Cancer
G. Zhang et al.
CURRENT GENOMICS (2010)
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2010)
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Li Ma et al.
NATURE CELL BIOLOGY (2010)
MicroRNA sponges: Progress and possibilities
Margaret S. Ebert et al.
RNA (2010)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Patsy Siok Hwa Soon et al.
CLINICAL CANCER RESEARCH (2009)
MicroRNA-122, a Tumor Suppressor MicroRNA that Regulates Intrahepatic Metastasis of Hepatocellular Carcinoma
Wei-Chih Tsai et al.
HEPATOLOGY (2009)
Management of Endocrine Manifestations and the Use of Mitotane As a Chemotherapeutic Agent for Adrenocortical Carcinoma
Irina Veytsman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
R. Juliano et al.
MOLECULAR PHARMACEUTICS (2009)
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival
Jinmai Jiang et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility
Marina N. Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Potential of solid lipid nanoparticles in brain targeting
Indu Pal Kaur et al.
JOURNAL OF CONTROLLED RELEASE (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
Suppression of non-small cell lung tumor development by the let-7 microRNA family
Madhu S. Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
microRNAs join the p53 network - another piece in the tumour-suppression puzzle
Lin He et al.
NATURE REVIEWS CANCER (2007)
Bacterially-derived nanocells for tumor-targeted delivery of chemotherapeutics and cell cycle inhibitors
Jennifer A. MacDiarmid et al.
CELL CYCLE (2007)
The let-7 MicroRNA represses cell proliferation pathways in human cells
Charles D. Johnson et al.
CANCER RESEARCH (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
Cyclin g1 is a target of miR-122a, a MicroRNA frequently down-regulated in human hepatocellular carcinoma
Laura Gramantieri et al.
CANCER RESEARCH (2007)
Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics
Jennifer A. MacDiarmid et al.
CANCER CELL (2007)
Requirement of bic/microRNA-155 for normal immune function
Antony Rodriguez et al.
SCIENCE (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
MicroRNA regulates the expression of human cytochrome P4501B1
Yuki Tsuchiya et al.
CANCER RESEARCH (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
Establishment and evaluation of cancer-specific human monoclonal antibody GAH for targeting chemotherapy using immunoliposomes
S Hosokawa et al.
HYBRIDOMA AND HYBRIDOMICS (2004)
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
Y Matsumura et al.
ANNALS OF ONCOLOGY (2004)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
